Spotting cancer at an early stage saves lives!
As a result, "RECOGNIZE IT IN TIME" became AveGene's primary motto and goal statement. It is essential to inform your physician as soon as possible if you observe something that is not typical for you.
Cancer screening is a molecular test that looks for early signs of cancer in people with no symptoms by detecting variants in DNA structure. It is important to understand that a diagnosis for each patient shall be made only after considering not just screening, but also other factors including biochemical examinations, physical condition, and more. Presence of certain DNA variants is a sign that something is happening and the patient shall care more.
Only authorized medical personnel are permitted to make diagnoses!
Efficient procedure for rapid screening of multiple critical diseases and genetic predispositions via blood samples utilizing Next Generation Sequencing technology. The World's most advanced technology for assessing health status at the molecular level is now accessible to you in the most discreet manner possible.
Please visit your pharmacy or local distributor to get your Sample collection kit based on your selected test(s). You can also order the kit from the e-shop at www.avegene.com, but local distributor may offer you attractive discounts.
Carefully verify the compatibility of the collection kit with the tests you want. At home collection is possible for tests that need only a small volume of blood or urine specimens. For the majority of tests, you need to go to a medical facility where you can request blood collection. Please utilize only those vials included in the collection kits!
Visit www.avegene.com e-shop and register at the health care portal (it will be created simultaneously once you begin your purchase). Once you have your test kit, enter its serial number and purchase the screening tests of your choice. Take advantage of discounts offered by local distributors and AveGene partners. The activation codes and unique password for accessing your test results are included within the sample collection kit.
Use transport accessories and prepare the sample according to the instructions included in the package. Next, forward the specimen to the closest collection centre or to the central collection laboratory of AveGene. Select a courier service that you prefer for the fastest delivery.(Use of public post is not allowed in most countries.)
Specimens received undergo an extensive check for DNA/RNA quality to confirm that no damage occurred during transportation. A portion of the sample is retained for backup control and it is submitted to the testing batch according to the selected test type.Several comprehensive steps occur from library preparation to sequencing, each supported by interim quality control checkups.
The sequencing outcome is subsequently managed by a genetic specialist before being submitted for final analysis to our oncologists. The final report has been created and encrypted as a PDF document. (Patients can also request original data files such as bedQ, FastQ, and others.) An online consultancy may also be requested, particularly in instances of specific positive outcomes. It is advisable that a consultation takes place between the patient's medical doctor and the AveGene oncologist to establish the quickest plan for further examination of the patient.
Sequencing is a technique used to ascertain the arrangement of nucleotides in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), as well as to establish the sequence of amino acids in proteins. In other words, it is a technique for identifying the matrix of ADGT nucleotides. To explain the method more; we isolate DNA/RNA samples from blood or plasma, decompose the matrix into billions of individual nucleotides, and then employ thorough bioanalytic techniques to analyse fragments that are specific or semi-specific to certain diseases. If specific fragments are identified, we also assess their frequency and assign a relative risk factor to each fragment. Certain fragments may also be evaluated in relation to other ones. Oncology diseases are often characterized by a wide variety of specific or semi-specific fragments. We use two primary approaches: the European CEGAT and the American ACME. Each association rates the pathogenic variants somewhat differently, but we strive to accommodate both perspectives. Read more at the HOW TO UNDERSTAND THE RESULTS page.
Learn more about the reports and how it should be understood. Please keep in mind the results shall always be consulted with your Medical Doctor who knows your physical status. This screening program shall act as an early detection alert. We do not provide diagnostics!
Oncogenic viruses like HPV, Hepatitis, or HIV, along with oncogenic agents such as heavy metals and radiation, play a crucial role in promoting genetic mutations, which is commonly called a cancer.
Human papilloma virus (HPV)
Human papilloma virus (HPV) comprises over 100 viruses that are typically transmitted through sexual contact. HPV is quite prevalent and has the potential to infect the skin, genital area, and throat, leading to specific cancers and genital warts in both men and women. Many infections are asymptomatic, leaving numerous individuals unaware of their infection status. The majority of new infections are found among young individuals in their teenage years and early twenties. While many infections resolve independently, the process may take as long as two years for complete resolution. Certain HPV infections that persist may advance to cancer. HPV is responsible for nearly all cases of cervical cancer in the US, as well as a significant number of cancers affecting the vulva, vagina, penis, anus, and the back of the throat. The most prevalent HPV-related cancer is oropharyngeal cancer, primarily affecting men. Individuals can transmit the virus without displaying any symptoms, and this can occur even if they were infected years prior.